The NYU Health Promotion and Prevention Research Center (NYU PRC) at the NYU School of Medicine announced it has received a $3.2 million award from the Centers for Disease Control and Prevention (CDC) to establish a Comparative Effectiveness Research Program focused on hypertension and colorectal cancer health disparities in African-American men in New York City. The NYU PRC is one of only four of the 37 PRC research facilities nationwide to receive this prestigious award. The program will build upon the center's commitment to build and enhance community capacity for health promotion and disease prevention across diverse populations in New York City.
The study will be led by R. Scott Braithwaite, MD, associate professor, Department of Medicine; Joseph Ravenell, MD, assistant professor, Department of Medicine; Mariano Rey, MD, principal investigator of the NYU PRC and director of the NYU Institute of Community Health and Research; and Chau Trinh-Shevrin, DrPH, assistant professor, Department of Medicine. The multidisciplinary research team will also include NYU Langone faculty investigators, the NYU School of Medicine's Division of General Internal Medicine, NYU Wagner Graduate School of Public Service, and the NYU College of Nursing. A diverse group of community-based and faith-based organization partners are also involved in this program.
"Addressing health disparities is a top priority for NYU, and this grant teams up our outstanding leaders in comparative effectiveness research with our superb Health Promotion and Prevention Research Center, working closely with community partners, to tackle some of the most important public health issues among African-American men."said Vivian S. Lee, MD, PhD, MBA, senior vice president, vice dean for science and chief scientific officer. "We are thrilled that the NYU PRC was recognized for being able to bring fresh scientific approaches to critical disease prevention and control issues, and that we are one of only four centers to receive this award from the CDC."
New research explores how omega-3 and omega-6 fatty acids may impact cancer rates